
| 10.1002/jmv.26036
http://scihub22266oqcxt.onion/10.1002/jmv.26036
 32437004!7280725!32437004
free
free
free
|  
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32437004.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
J+Med+Virol 2020 ; 92 (10): 1818-1824 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
|
Hepatic complications of COVID-19 and its treatment #MMPMID32437004Tian D; Ye QJ Med Virol 2020[Oct]; 92 (10): 1818-1824 PMID32437004show ga
Coronavirus disease 2019 (COVID-19) is highly contagious and has a variety of clinical manifestations, it can affect a number of other organs in addition to the lungs, and liver injury may occur. Severe acute respiratory syndrome coronavirus 2 can cause liver injury through systemic inflammatory response syndrome, cytokine storms, ischemia-reperfusion injury, side effects of treatment drugs, and underlying liver disease and can attack liver cells directly via angiotensin-converting enzyme 2. Clinical studies have found that liver injury in COVID-19 patients mainly manifests as abnormal liver biochemical indicators, but there have been no reports of liver failure caused by this disease. The number of COVID-19 patients with liver injury is increasing, and the incidence of liver injury in COVID-19 patients with severe disease are higher than in patients with mild disease. Liver injury may be a risk factor, which worsens in patients with COVID-19, and hence it is necessary to pay attention to the occurrence of liver injury in the diagnosis and treatment of COVID-19.|Animals[MESH]|COVID-19/*complications/virology[MESH]|Humans[MESH]|Liver Diseases/*drug therapy/*etiology/virology[MESH]|Liver/drug effects/virology[MESH]|Pandemics/prevention & control[MESH]|Pneumonia, Viral/complications/virology[MESH]
  
DeepDyve Pubget Overpricing | 
|